This analysis is based on the Prasol Chemicals IPO analysis Offer Document dated September 03, 2026. For the educational purpose, IPOStack have evaluated the trust’s structure, assets, and financial projections.

Prasol Chemicals SNAPSHOT

• Company Name, Industry & Business Model: Prasol Chemicals Limited is a prominent Indian specialty chemicals manufacturer specializing in complex, forward-integrated chemistries across two core chemistry platforms: acetone-based and phosphorous-based derivatives, alongside customized specialty additives. The company operates on a B2B/B2B2C model catering to five major downstream industries: performance chemicals (lubricant additives/mining), paints, inks, construction & adhesives (PICA), pharmaceuticals, agrochemicals, and home & personal care.
• IPO Type & Size: Both Fresh Issue and Offer for Sale (OFS) aggregating to ₹500.00 crore.
  • Fresh Issue: Up to ₹80.00 crore (₹800.00 million; ~11,83,431 equity shares).
  • Offer for Sale (OFS): Up to ₹420.00 crore (₹4,200.00 million; ~6,213,006 equity shares).
• Price Band, Lot Size, Issue Dates & Listing:
  • Price Band: ₹643 to ₹676 per equity share of face value ₹2 each.
  • Lot Size: 22 Equity Shares (Minimum retail commitment: ₹14,872 at the upper band).
  • Issue Dates: Opens on Tuesday, September 8, 2026; Closes on Thursday, September 10, 2026.
  • Listing Exchanges: BSE and NSE (NSE is the Designated Stock Exchange).
• Market Capitalization: At the upper price band (₹676/share) on a post-issue equity base of ~5,91,83,431 shares, total market capitalization stands at ~₹4,000.80 crore.

OBJECTS OF THE OFFER of Prasol Chemicals:

The Net Proceeds of the Fresh Issue (~₹80.00 crore gross) are deployed as follows:

• Repayment/Prepayment of Certain Borrowings: ₹60.00 crore (₹600.00 million) allocated to deleverage short-term and long-term credit facilities.
• General Corporate Purposes (GCP): Balance net proceeds (~₹20.00 crore gross, net of fresh issue expenses).
• Debt Repayment Flag: 75% of the Fresh Issue proceeds are dedicated to debt prepayment/repayment. While this de-risks the capital structure and improves interest coverage, none of the fresh issue proceeds are allocated to greenfield or brownfield capacity expansion.
• GCP Proportion Flag: GCP is strictly maintained within the regulatory ceiling of ≤ 25% of Gross Proceeds in accordance with SEBI ICDR regulations.
• Verdict: The IPO is overwhelmingly an EXIT for existing shareholders. The OFS makes up 84.00% of the entire issue (₹420 crore out of ₹500 crore), leaving only a modest amount of primary equity to retire debt.

FINANCIAL ANALYSIS (FY24 – FY26) – Prasol Chemicals:

Metric (₹ in million)	FY 2024 (Consolidated)	FY 2025 (Consolidated)	FY 2026 (Standalone)
Revenue from Operations	8,765.65	10,124.94	12,325.93
Other Income	109.95	30.60	52.52
Total Income	8,875.60	1,0155.54	12,378.45
EBITDA	605.30	877.70	1,393.20
Restated PAT	181.30	435.70	831.24
Diluted EPS (₹)	3.13	7.51	14.33
Total Borrowings	820.70	1,010.50	1,100.60
Total Equity (Net Worth)	3,258.35	3,674.55	4,485.05
Cash from Operations (OCF)	1,156.06	222.60	494.70

• Revenue Growth Trend: Revenue expanded at an 18.58% CAGR between FY24 and FY26, climbing from ₹8,765.65 million to ₹12,325.93 million. Growth was led by export volume expansion and improved pricing in phosphorus chemistries.
• Profitability & Operating Leverage: Net profit experienced sharp acceleration, growing from ₹181.30 million in FY24 to ₹831.24 million in FY26. PAT margins expanded from 2.06% in FY24 to 6.74% in FY26, while EBITDA margin improved to 11.30%.
• Debt Dynamics: Total borrowings rose from ₹820.70 million in FY24 to ₹1,100.60 million in FY26. However, leverage remains conservative with a Net Debt-to-Equity ratio of 0.19x and a comfortable Debt Service Coverage Ratio (DSCR) of 5.38x in FY26.
• Operating Cash Flow (OCF): Operating cash flow has shown high volatility—dropping from ₹1,156.06 million in FY24 to ₹222.60 million in FY25 before partially recovering to ₹494.70 million in FY26. This divergence from PAT reflects working capital expansion and tax adjustments.
• Return Ratios: Capital efficiency has improved noticeably, with Return on Equity (ROE) reaching 20.37% and Return on Capital Employed (ROCE) at 22.43% in FY26.
• Working Capital Cycle: Net working capital days lengthened from 35 days in FY24 to 49 days in FY26 (Inventory days: 65, Trade receivable days: 71, Trade payable days: 87). Total trade receivables reached ₹2,786.86 million (22.51% of total income).

Prasol Chemicals — VALUATION & PEER COMPARISON:

• Peer Group Multiples: The RHP identifies comparable specialty chemical manufacturers:
  • Aarti Industries Limited: P/E ~38x – 42x | RoNW ~10.5%
  • Atul Limited: P/E ~45x – 48x | RoNW ~11.2%
  • Vinati Organics Limited: P/E ~42x – 46x | RoNW ~15.8%
  • Clean Science and Technology Limited: P/E ~50x – 55x | RoNW ~22.0%
• IPO Valuation Multiples:
  • FY26 Diluted EPS: ₹14.33
  • P/E at Lower Price Band (₹643): 44.87x
  • P/E at Upper Price Band (₹676): 47.17x
  • Post-Issue P/E (FY26 Post-Issue Shares): ~48.13x
  • Price-to-Book (P/B): ~8.74x based on FY26 Net Asset Value of ₹77.33.
• Valuation Verdict: EXPENSIVE. Asking for a P/E multiple of ~47x–48x leaves limited margin of safety for investors. While Prasol’s 2-year profit growth has been strong, its EBITDA margin profile (11.30%) and absolute PAT margin (6.74%) remain significantly lower than pure-play specialty peers like Clean Science and Vinati Organics (>20% PAT margins). The issue is fully priced.

PROMOTER & MANAGEMENT ANALYSIS of Prasol Chemicals:

• Promoters: Nishith Rajnikant Shah (Chairman & Whole-Time Director), Gaurang Natwarlal Parikh (Managing Director), Dhaval Nalin Parikh (Joint Managing Director), Pankil Nishith Dharia, Sachin Jatin Parikh, Rakesh Gupta, Nishith Rasiklal Dharia, Kunal Tushar Dharia, Suketu Navinchandra Parikh, and Usha Rajnikant Shah. Management possesses 20–30+ years of operational tenure in industrial organic synthesis.
• Shareholding Profile:
  • Pre-IPO Promoter & Promoter Group Holding: 89.20%.
  • Post-IPO Promoter & Promoter Group Holding: Dilutes to ~77.51%.
• Promoters Selling in OFS: 16 promoter and promoter group entities are selling a combined ₹323.55 crore out of the ₹420.00 crore OFS, with their weighted average cost of acquisition (WACA) ranging between ₹2.23 and ₹62.50 per share.
• Promoter Pledging: Nil promoter equity shares are pledged.
• Management Departures & Integrity Flags:
  • The Deputy Director of Industrial Safety & Health (DISH), Raigad, issued show-cause notices against Managing Director Gaurang Natwarlal Parikh (as factory occupier) under Section 7A(2)(a) of the Factories Act, 1948.
  • Four directors (Gaurang Parikh, Nishith Shah, Dhaval Parikh, and G Ramakrishnan) were historically directors of entities that were voluntarily struck off by the RoC for being inoperative.
  • One promoter (Usha Rajnikant Shah) has untraceable educational qualification documents, relying on an affidavit.

RISK FACTORS (TOP 10 CRITICAL RISKS):

1. Regulatory Shutdowns & Safety Track Record: Multiple severe historical shutdowns ordered by the Maharashtra Pollution Control Board (MPCB). In October 2023, a toxic gas leak ($H_2S$ and $SO_2$) at the Mahad plant caused 1 fatality and 4 hospitalizations, halting operations for over 6 months until May 2024. An earlier November 2022 chemical transfer accident also caused 1 fatality. (HIGH Severity)
2. High Import Feedstock Dependency: 65.96% of total raw materials are imported (from China, Thailand, Europe, etc.), exposing gross margins to global shipping disruptions, import tariff shifts, and foreign exchange fluctuations. (HIGH Severity)
3. Elevated Contingent Liabilities & Commitments: Aggregate contingent liabilities and commitments stand at ₹1,091.22 million (24.33% of Net Worth), primarily consisting of ₹82.71 crore in letters of credit and disputed tax/customs claims. (HIGH Severity)
4. Heavy Issue Skew Towards Promoter OFS: 84.00% of the IPO proceeds (₹420.00 crore) represent promoter and promoter group selling shareholders monetizing their holdings. The company receives only ₹80.00 crore. (HIGH Severity)
5. Auditor Modifications on Internal Controls: Statutory auditors issued modified opinions regarding internal financial controls over inventory valuation, citing deficiencies in quantitative tracking, stage-wise valuation, and manual overhead allocations in FY24, FY25, and FY26. (MEDIUM Severity)
6. Volatile Raw Material Feedstock Prices: Acetone and yellow phosphorus constitute the primary feedstocks. Feedstock price swings cannot always be passed on immediately due to purchase-order-based non-contractual selling. (MEDIUM Severity)
7. Underutilization at Mahad Facility: The Mahad plant operated at an annualized capacity utilization of only 44.09% in FY26 (25.18% in FY25), reporting ongoing segment losses of ₹121.72 million before tax. (MEDIUM Severity)
8. Lack of Long-Term Client & Supplier Commitments: The company operates on spot and purchase-order commitments without long-term volume or pricing contracts. Top 10 customers represent 23.68% of operational revenue. (MEDIUM Severity)
9. Volatile Operating Cash Flow Conversion: OCF dropped significantly from ₹1,156.06 million in FY24 to ₹222.60 million in FY25 and ₹494.70 million in FY26 due to working capital expansion. (MEDIUM Severity)
10. High Workforce Attrition: Employee attrition stood at 27.96% in FY26 (36.82% in FY24 following the Mahad factory closure). (LOW-TO-MEDIUM Severity)

OFS & SHAREHOLDER ANALYSIS of Prasol Chemicals:

• OFS Proportion: 84.00% of the total issue size (₹420.00 crore OFS vs. ₹80.00 crore Fresh Issue).
• Selling Shareholders: Exclusively family promoter/promoter group members and early non-promoter individuals. No institutional private equity or venture capital funds are in the selling block.
• Promoter Cost of Acquisition: Extremely low weighted average cost of acquisition (Usha Shah: ₹9.77, Gaurang Parikh: ₹4.81, Suketu Parikh: ₹2.54, Sachin Parikh: ₹50.13) against the offer price of ₹676.
• Promoter Post-IPO Lock-in: 20% minimum promoter contribution locked for 18 months, with the remainder locked for 6 months per SEBI ICDR guidelines.
• Verdict: The OFS proportion (>50%) is a clear RED FLAG. The transaction functions primarily as an avenue for promoter profit-booking rather than a capital-raising event for manufacturing expansion.

LITIGATION & LEGAL RISKS of Prasol Chemicals:

• Summary of Proceedings:
  • Against Company: 9 tax proceedings, 16 statutory/regulatory proceedings, 1 material civil litigation (Total quantifiable exposure: ₹61.83 million).
  • Against Promoters: 6 criminal proceedings (primarily labour/safety-related citations and dishonoured cheque defenses), 4 tax cases, 1 regulatory action (Total quantifiable exposure: ₹28.02 million).
  • Criminal / Labor Penalties: JMFC Mahad convicted and fined the company and executive directors in June 2024 for non-compliance with the Minimum Wages Act and Payment of Wages Act.
  • MPCB Enforcement History: Multiple plant closures, show causes, and industrial accident investigations over the past 5 years.
• Severity: Significant. While financial claims are manageable relative to net worth, repeated environmental and plant safety infractions present persistent operational risk.

RELATED PARTY TRANSACTIONS

• Key Transactions:
  • Total related party transactions stood at ₹148.14 million in FY26 (1.20% of revenue from operations).
  • Key transactions consist of executive director remuneration, short-term lease/rent expenses, and a historic land purchase in Jan 2022 from directors (₹44.10 million) for green belt expansion.
• Verdict: Related party exposure is within normal operational parameters, conducted on arm’s-length terms, and does not exhibit predatory value extraction.

RED FLAG SCORECARD of Prasol Chemicals:

Red Flag	Score (0–3)	Notes
High/Rising Debt	0	Low leverage; Net D/E is 0.19x; ₹60 Cr used to prepay debt.
Negative Operating Cash Flow	1	Positive OCF, but highly volatile and lagging net profit.
High OFS Component (>50%)	3	84.00% OFS (Promoter profit booking).
Promoters Selling Large Stake	2	Promoters offloading substantial shares across 16 family accounts.
Expensive Valuation vs Peers	2	P/E of ~47x–48x is rich for ~11% EBITDA margin profile.
Frequent/Serious Litigation	2	Recurring MPCB plant shutdowns and 2 fatal industrial accidents.
Related Party Concerns	1	Historic land transaction with promoters; otherwise within limits.
Weak/Unproven Business Model	0	Established 30+ year track record; 150+ products across 69 countries.
Loss-Making with No Profit Path	0	Strong PAT trajectory (₹83.12 Cr in FY26).
Low Promoter Post-IPO Holding	0	Strong post-issue promoter holding (~77.51%).

Total Score: 11 / 30 — CAUTION

(Driven by the heavy 84% OFS structure, rich valuation multiples, and plant safety/MPCB regulatory risks).

FINAL VERDICT

❌ DO NOT APPLY (AVOID / NEUTRAL)

Investment Thesis

Prasol Chemicals is an established player in acetone and phosphorus specialty chemistries with a diversified export footprint spanning 69 countries. While financial metrics show impressive FY26 net profit acceleration and high returns on capital (ROCE 22.43%), the IPO structure is unfavorable for incoming minority investors. At an upper price band of ₹676, the issue is priced at ~48x FY26 earnings, pricing the company at parity with established Tier-1 specialty chemical leaders that possess superior margin profiles (>20% EBITDA) and cleaner safety track records. Furthermore, with 84% of the issue comprising an Offer for Sale and zero fresh capital channeled into capacity expansion, the risk-reward equation is skewed unfavorably.

Key Reasons Supporting the Verdict

• Stretched Valuation Multiple: Demanding ~48x P/E on FY26 earnings leaves minimal margin of safety, particularly given historical EBITDA margins of 8%–11% and lower PAT margins (6.74%).
• Predominant Promoter Cash-Out: ₹420.00 crore of the ₹500.00 crore offer is an OFS across promoter family accounts, limiting company-level benefits from the listing.
• Safety & Regulatory Vulnerability: The operational history is marked by repeated environmental closures by the MPCB and two fatal industrial accidents at the Mahad facility.
• Auditor Reservation on Inventory Controls: Repeated audit modifications regarding internal controls over inventory valuation indicate systems that require institutional upgrades.

Category Recommendation

• Avoid entirely: Investors seeking specialty chemical exposure can find more attractive valuations, higher margins, and cleaner operational track records in established listed alternatives.

Key Risks to Watch Post-Listing

• Mahad Plant Turnaround: Execution on margin recovery and capacity utilization ramp-up at Mahad (currently at 44%).
• Feedstock Price Volatility: Any sharp run-up in imported acetone and yellow phosphorus prices without corresponding downstream pass-through.
• Regulatory Scrutiny: Environmental monitoring and compliance outcomes with the MPCB and local authorities.

Disclaimer: The information provided on IPO Stack (https://ipostack.in) is for informational and educational purposes only and should not be considered financial, investment, or trading advice. While we strive to ensure that the information published on our website is accurate and up to date, IPO Stack does not guarantee the completeness, reliability, or accuracy of any information presented.